levocetirizine 2.5 mg + montelukast 4 mg DT tablets

Buy levocetirizine 2.5 mg + montelukast 4 mg DT tablets for Bulk Order

What is levocetirizine 2.5 mg + montelukast 4 mg DT tablets?

Levocetirizine 2.5 mg + Montelukast 4 mg DT tablets are a pharmaceutical combination used in the treatment of allergic rhinitis and asthma. Levocetirizine, an antihistamine, alleviates allergy symptoms, while Montelukast, a leukotriene receptor antagonist, reduces inflammation and bronchoconstriction.

This combination is classified under anti-allergic and respiratory agents, making it valuable in both clinical and research settings. Regulatory authorities recognize its efficacy, and it is commonly prescribed for patients with seasonal or perennial allergies.

What Are the Applications of levocetirizine 2.5 mg + montelukast 4 mg DT tablets?

• Pharmaceutical formulation for allergic conditions.
• Research on respiratory disorders and allergy treatments.
• Therapeutic applications in combination therapies for enhanced efficacy.
• Potential use in clinical trials assessing patient responses.

Why Choose Pharmint as Your levocetirizine 2.5 mg + montelukast 4 mg DT tablets Supplier?

Pharmint offers global sourcing capabilities, ensuring you receive high-quality levocetirizine + montelukast tablets. We provide a Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) to guarantee compliance with regulatory standards.

Our bulk availability, short lead times, and dedicated export support distinguish us from typical vendors, allowing for seamless procurement processes.

Storage & Handling Guidelines for levocetirizine 2.5 mg + montelukast 4 mg DT tablets

Store levocetirizine 2.5 mg + montelukast 4 mg DT tablets in a cool, dry place at temperatures between 15°C to 25°C. Protect from light and moisture to maintain stability. The product is typically available in bulk packaging suitable for both research and commercial use.

Regulatory, Documentation & Export Information

This product is not classified as a controlled precursor and does not require an end-use declaration. Available documentation includes a Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) for safety and quality assurance.

levocetirizine 2.5 mg + montelukast 4 mg DT tablets FAQs

1. What are the main uses of levocetirizine + montelukast?

These tablets are primarily used for treating allergic rhinitis and asthma, providing relief from allergy symptoms and reducing airway inflammation.

2. How should levocetirizine + montelukast be stored?

Store at 15°C to 25°C in a cool, dry environment, away from light and moisture to ensure product stability.

3. Is the product compliant with regulatory standards?

Yes, our levocetirizine + montelukast tablets come with a COA and MSDS, ensuring adherence to relevant regulatory requirements.

4. What packaging options are available for bulk orders?

We offer bulk packaging suitable for both commercial and research-grade applications, facilitating easy handling and storage.

5. Can I get documents for procurement purposes?

Yes, we provide necessary documentation, including COA and MSDS, to support procurement processes and compliance audits.